Cisplatin plus vindesine versus cisplatin plus VP16 versus doxorubicin plus cytoxan in non-small-cell carcinoma of the lung. A randomized study

A. Paccagnella, A. Brandes, G. L. Pappagallo, G. Simioni, V. P. Fosser, O. Vinante, L. Salvagno, P. De Besi, V. Chiarion Sileni, A. Fornasiero

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)417-425
Number of pages9
JournalTumori
Volume72
Issue number4
Publication statusPublished - 1986

ASJC Scopus subject areas

  • Cancer Research

Cite this

Paccagnella, A., Brandes, A., Pappagallo, G. L., Simioni, G., Fosser, V. P., Vinante, O., Salvagno, L., De Besi, P., Chiarion Sileni, V., & Fornasiero, A. (1986). Cisplatin plus vindesine versus cisplatin plus VP16 versus doxorubicin plus cytoxan in non-small-cell carcinoma of the lung. A randomized study. Tumori, 72(4), 417-425.